BioNTech SE
NASDAQBNTX heads into the final weeks before its August 4 earnings print with analyst sentiment firmly positive, short sellers retreating, and options traders less defensive than they've been all year. The most interesting angle this week is the divergence between where analysts think the stock should be and where it actually trades. The Street consensus is a buy rating with a mean price…
BNTX cost to borrow spikes 289% in one week to 1.80%, highest level in months amid tight short availability.
Snapshot as of 22 Jun 2026
BNTX heads into the final weeks before its August 4 earnings print with analyst sentiment firmly positive, short sellers retreating, and options traders less defensive than they've been all year. The most interesting…
BNTX arrives at its May 15 earnings date with the stock nursing a 6.4% weekly loss, analysts trimming targets, yet a Street consensus that remains broadly constructive — the question is whether the pipeline can justify…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BNTX — free to start on ORTEX.
Sign up for free →Open BNTX on ORTEX